Next Quarterly Earnings
Thursday, August 6, 2026
CW 32
After-Hours
In 32 days
Iovance Biotherapeutics
Iovance Biotherapeutics is a leading US biopharmaceutical company dedicated to the development and commercialization of innovative cell therapies for cancer patients. It is transforming cancer treatment through its unique tumor-infiltrating lymphocyte (TIL) therapy within the field of cancer immunotherapy, offering new hope for those affected.
All Dates
Earnings history data not available
Company Information
Name
Iovance Biotherapeutics
Country
🇺🇸
More Financial Information